Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Supplemental Warning Regs Need Not Show Causation – FDA’s Troy

This article was originally published in The Tan Sheet

Executive Summary

FDA does not have to prove causality in order to require new warnings in the labeling of OTC drugs, Chief Counsel Daniel Troy clarified at the Generic Pharmaceutical Association's legal symposium in Washington, D.C. May 16
Advertisement

Related Content

Reye’s Syndrome Warning Will Not Apply To Salicylate Inactive Ingredients
Diphenhydramine Poison Ivy Caution Not Required On External Analgesics
Diphenhydramine Poison Ivy Caution Not Required On External Analgesics

Topics

Advertisement
UsernamePublicRestriction

Register

PS095510

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel